Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Eric T. Wong, MD
Beth Israel Deaconess Medical Center
Study Director - Herbert H. Engelhard, MD, PhD
University of Illinois at Chicago
Study Director - Manfred Westphal, Prof. MD
Universitätsklinikum Hamburg-Eppendorf
Study Director - Philip H. Gutin, MD
Memorial Sloan Kettering Cancer Center
Study Director - Roger Stupp, MD
University Hospital, Zürich
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
89 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University Hospital Graz
Graz, Austria
- Medical University of Vienna
Vienna, Austria
- Smz-Süd/kaiser-Franz-Josef-Spital
Vienna, Austria
- Tom Baker Cancer Center
Calgary, Alberta, Canada
- Cancercare Manitoba
Winnipeg, Manitoba, Canada
- Juravinski Cancer Centre
Hamilton, Ontario, Canada
- the Ottawa Hospital Cancer Centre
Ottawa, Ontario, Canada
- Mcgill - Gerald Bronfman Centre for Clinical Research in Oncology -
Montreal, Quebec, Canada
- Montreal Neurological Institute
Montreal, Quebec, Canada
- Notre-Dame Hospital (chum)
Montreal, Quebec, Canada
- (chus) Centre Hospitalier Universitaire de Sherbrooke, Service de Neurochirurgie
Sherbrooke, Quebec, Canada
- Na Homolce Hospital
Prague, Czechia
- Chu Amiens Sud-Salouel
Amiens, France
- Chu Angers
Angers, France
- Hôpital Saint André Centre Hospitalier Universitaire (chu) Des Hôpitaux de Bordeaux
Bordeaux, France
- Hospital of Neurology Pierre Wertheimer
Lyon, France
- Group Hospitals Pitie-Salpetriere
Paris, France
- Centre Hospitalo-Universitaire de Toulouse Purpan
Toulouse, France
- University Medical Center Hamburg-Eppendorf
Hamburg, Germany
- Medical University Heidelberg
Heidelberg, Germany
- University Hospital of Schleswig-Holstein
Kiel, Germany
- Tel Aviv Sourasky Medical Center
Tel Aviv, Israel
- Az. Ospedaliero-Universitaria - Ospedali Riuniti
Ancona, Italy
- Ospedale Lecco
Lecco, Italy
- C. Besta Neurological Institute
Milan, Italy
- Foundation Hospital Greater Policlinico
Milan, Italy
- Istituti Fisioterapici Ospitalieri - Istituto Nazionale Dei Tumori Regina Elena
Rome, Italy
- Asan Medical Center
Asan, South Korea
- Yeungnam University Hospital
Daegu, South Korea
- Chungnam National University Hospital (cnuh)
Daejeon, South Korea
- Samsung Medical Center (smc)
Seoul, South Korea
- Seoul National University Bundang Hospital (snubh)
Seoul, South Korea
- Seoul National University Hospital (snuh)
Seoul, South Korea
- the Catholic University of Korea, Seoul St. Mary'S Hospital (cmc Seoul)
Seoul, South Korea
- Yonsei University Severance Hospital (yuhs)
Seoul, South Korea
- Ajou University Hospital (auh)
Suwon, South Korea
- Hospital Universitari Germans Trias I Pujol
Badalona, Spain
- Hospital Clinic I Provincial de Barcelona
Barcelona, Spain
- Hospital Universitari de Bellvitge-Ico Duran I Reynals
Barcelona, Spain
- Hospital del Mar
Barcelona, Spain
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2009
- Primary completion
- 31 Dec 2016
- Completion
- 31 Mar 2017
- Last update posted
- 10 Apr 2017
- Registered enrollment
- 700
- Registry id
- NCT00916409
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.